Cogent Biosciences Inc (NAS:COGT)
$ 8.7 -0.1 (-1.14%) Market Cap: 831.84 Mil Enterprise Value: 647.29 Mil PE Ratio: 0 PB Ratio: 4.16 GF Score: 30/100

Cogent Biosciences Inc to Host ASH Investor Event Transcript

Dec 11, 2023 / 01:00PM GMT
Release Date Price: $4.06 (-53.01%)
Operator

Yes, good morning, and welcome to Cogent Biosciences webcast. I will now turn the call over to Christi Waarich, Senior Director of Investor Relations.

Christi Waarich
Cogent Biosciences, Inc. - IR

Thank you, operator. For today's call, we'll review the summer and APEX data value embedded cancer in patients with non there in advanced systemic mastocytosis. These data were presented and released in the press release over the weekend and earlier this morning, you can find the press release in the Investors and Media section of our website at cogentco.com.

Before we get started, please be reminded that remarks made during this call may be forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines, including future presentations of clinical data financial projection.

While these forward-looking statements represent our views as of today, they should not be relied upon as representing our views in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot